From the National Center for Advancing Translational Sciences
From the National Institutes of Health
6th Biennial Symposium International Eosinophil Society Post-Symposium Workshop
Sunday, July 12, 2009
The short-term goals of this workshop were to (1) identify and prioritize the most promising new agents for multicenter treatment trials for rare eosinophil-mediated disorders and (2) continue to foster collaborative relationships between multidisciplinary clinical and basic science researchers interested in eosinophil-mediated disease. It was anticipated that this would lead to the design of one or more multicenter clinical trials to assess the safety and efficacy of novel agents for the treatment of rare eosinophil-mediated disorders.
Contact: Dr. Amy Klion (301) 435-8903
National Institute of Allergy and Infectious Diseases